Parkinson’s Disease

Latest News

Inappropriate Antipsychotics Raise Pneumonia Risk in Older Adults With Parkinson Disease

By

Brandon May

Patients with Parkinson disease (PD) who use inappropriate antipsychotics may be at an increased risk for pneumonia compared with patients with PD who use more appropriate atypical antipsychotics.

Bipolar Disorder Associated With Increased Risk for Parkinson Disease

By

Brandon May

Published studies that included data on the risk for PD in patients with BD vs the general population without BD were included in a systematic review.

Nourianz Now Available for Patients With Parkinson Disease Experiencing “Off” Episodes

By

Steve Duffy

Nourianz is now available as an adjunctive treatment to levodopa/carbidopa in adult patients with Parkinson disease (PD) experiencing “off” episodes.

FDA Cracks Down on Company Selling CBD Products With Unapproved Therapeutic Claims

By

Steve Duffy

The Food and Drug Administration (FDA) has issued a warning letter to Curalef Inc. of Wakefield, Massachusetts for illegally selling unapproved cannabidiol (CBD) products online with unsubstantiated health claims.

Suicidal Behavior Seen After Deep Brain Stimulation for Parkinson Disease

By

Brandon May

In patients with Parkinson disease who receive subthalamic nucleus deep brain stimulation, suicide behaviors tend to occur during the first 3 years after the procedure.

Recommendations for Screening and Rating Impulse Control Disorders in Parkinson Disease

By

Psychiatry Advisor Contributing Writer

International Parkinson’s and Movement Disorder Society released recommendations on clinical screening instruments and rating scales used to measure impulsive and compulsive behaviors in Parkinson disease.

Parkinson Disease Risk Increased in Bipolar Disorder

By

Laurel Ranger

More frequent manic/mixed and depressive episodes were associated with an increased risk for Parkinson disease.

Valproate as Inciting Agent in New or Worsened Parkinsonian Symptoms

By

Psychiatry Advisor Contributing Writer

Parkinsonism is a lesser known debilitating adverse effect associated with valproate, especially in older patients.

Pimavanserin and Quetiapine Comparable for Psychosis in Parkinson Disease

By

Psychiatry Advisor Contributing Writer

There were no significant differences between pimavanserin and quetiapine in time to discontinuation, mortality, or improvement in psychosis in patients with Parkinson disease and Lewy body dementia.

Cognitive Decline in Parkinson Disease Linked With Alzheimer Genetic Variants

By

Psychiatry Advisor Contributing Writer

Multiple genetic risk loci for Alzheimer disease predict longitudinal cognitive decline in patients with Parkinson disease without dementia.